TrialMedical oncology (Northwood, London, England)2023

PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.

Giulio Francolini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.